참고문헌
- Bauer, A. W., M. Kirby, J. C. Sherris, and M. Turck. 1966. Antibiotic susceptibility testing by a standardized single disc method. Am. J. Clin. Pathol. 45: 493
- Barna, J. C. J. and D. H. Williams. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Ann. Rev. Microbiol. 38: 339-357 https://doi.org/10.1146/annurev.mi.38.100184.002011
- Cheong, H. J. 1997. Vancomycin resistant enterococci. J. Korean Soc. Chemother. 15: 27-43
- Chesneau, O., A. Morvan, and N. E. Solh. 2000. Retrospective screening for heterogeneous vancomycin resistance in deverse Staphylococcus aureus clones disseminated in French hospitals. J. Antimicrob. Chemother. 45: 887-890 https://doi.org/10.1093/jac/45.6.887
- Cohen, S., M. M. Morita, and M. Bradford. 1991. A seven-tear experience with methicillin-resistant Staphylococcus aureus. Am. J. Med. 91(Suppli3B): 233S-237S https://doi.org/10.1016/0002-9343(91)90374-7
- Corti, A. and G. Cassani. 1985. Synthesis and Characterization of D-alanyl-D-alanine-agarose: A new bioselective adsorbent for affinity chromatography of glycopeptide antibiotics. Appl. Biochem. Biotechnol. 11: 101-110 https://doi.org/10.1007/BF02798542
- Corti, A., A. Soffientini, and G. Cassani. 1985. Binding of the glycopeptide antibiotic teicoplanin to D-alanyl-D-alanine-agarose: The effect of micellar aggregates. J. Appl. Biochem. 7: 133-137
- Ferraz, V., A. G. Duse, M. Kassel, A. D. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J. 90: 1113
- Good, V. M., M. N. Gwynn, and D. J. Knowles. 1990. MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacelyl-L-lysyl-D-alanyl-D-alanine. J. Antibiot. 43: 550-555
- Hackbarth, C. J. and H. F. Chambers. 1989. Methicillin resistant Staphylococci: Detection methods and treatment of infections. Antimicrob. Agents Chemother. 33: 995-999
- Hood, J., G. F. S. Edwards, B. Cosgrve, E. Curran, D. Morrison, and G. G. Gemmell. 2000. Vancomycin-intermediate Staphylococcus aureus at a Scottish hospital. J. Infect. 40: All
- Jevons, M. P. A., W. Coe, and M. T. Parker. 1963. Methicillin resistance in Staphylococcus. Lancet 1: 904
- Kim, M. N., C. H. Pai, J. H. Woo, J. S. Ryu, and K. Hiramatsu. 2000. Vancomycin intermediate Staphylococcus aureus in Korea. J. Clin. Microbiol. 38: 3879-3881
- Knox, R. and J. T. Smith. 1961. The nature of Penicillin resistance in Staphylococci. Lancet 2: 520-522
- Leclereq, R. E., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin. New Engl. J. Med. 319: 157-161
- Lee, M. J., D. S. Lim, M. S. Lee, W. H. Yoon, and C. H. Kim. 1997. Characterization of Streptomyces sp. AMLK-135 producing anti-MRSA antibiotics. J. Microbiol. Biotechnol. 7: 397-401
- Mandell, G. L., R. G. Douglas, and J. E. Bennett. 1990. Principles and practice of infectious disease, pp. 1489. 3rd ed. Churchill Livingstone, New york, U.S.A
- Maple, P. A., J. M. Hamilton-Miller, W. Brumfitt. 1989. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet. 1: 537-540
- Rhee, K. H., K. H. Chio, C. J. Kim, and C. H. Kim. 2001. Identification of Streptomyces sp. AMLK-335 producing antibiotic substance inhibitory to vancomycin-resistant Enterococci. J. Microbiol. Biotechnol. 11: 469-474
- Smith, T. L., M. L. Pearson, and K. R. Wilcox. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. New Engl. Med. 340: 489-501